|
Aug 1
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Down Over 4% for Week
|
|
Jul 31
|
European Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics
|
|
Jul 28
|
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings
|
|
Jul 28
|
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
|
|
Jul 24
|
Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
|
|
Jul 23
|
Discovering Opportunities: 3 Penny Stocks With Market Caps Over $200M
|
|
Jul 21
|
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
|
|
Jul 21
|
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
|
|
Jul 16
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 1
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
|
|
Jun 29
|
Autolus Therapeutics (AUTL) Presents Positive Long-Term Obe-cel Data at EHA 2025
|
|
Jun 20
|
Syncona Ltd (LSE:SYNC) Full Year 2025 Earnings Call Highlights: Navigating Market Challenges ...
|
|
Jun 17
|
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
|
|
Jun 12
|
Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
|
|
Apr 16
|
April 2025's Top Penny Stocks To Watch
|
|
Dec 30
|
Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?
|
|
Oct 17
|
Autolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy
|
|
Oct 16
|
Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
|
|
Oct 16
|
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts
|
|
Oct 9
|
Autolus Therapeutics PLC (AUTL) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|